The Most Common Organ Disease You've Never Been Tested For

Welcome to The Longevity Playbook.

If you're here, you're already part of the High Performance Playbook community, which means you've been following along on mindset, money, and building a life that actually works. This is the other half of that equation: your body.

Because here's the truth. None of it matters if you're running on empty. The deals, the wins, the ambition, all of it is downstream of your health. A healthy person has a thousand goals. A sick person has one.

So I built this. A no-fluff newsletter on the stuff actually moving the needle right now: GLP-1s, peptides, longevity science, hormone optimization, and the protocols I'm personally testing through Kora MD®.

Real strategies, plain language, zero hype.

Same voice you already know. New focus. I'm not here to give you information you can Google or pull from ChatGPT. I'm here to give you the blueprint that real wellness professionals, longevity doctors, and athletes are using in 2026.

Let's get to work.

Hey ,

There's a condition that affects roughly one in three adults worldwide.

It usually causes no symptoms.

It often doesn't show up on standard blood tests.

Most healthcare systems don't screen for it.

And for the people who have it, the biggest threat isn't the organ involved.

It's their heart.

It's fatty liver, now called MASLD, which stands for metabolic dysfunction-associated steatotic liver disease. The name is a mouthful, but the shift behind it matters.

For years, this was framed as a drinking problem. We now understand it as a metabolic one, and it's become one of the most common chronic conditions on the planet.

What's Actually Happening

Your liver isn't designed to store much fat. When your body is dealing with insulin resistance and a steady surplus of energy, especially from sugar and refined carbohydrates, the liver becomes a dumping ground for the excess.

At first that fat is relatively quiet. Over time, in some people, it starts to drive inflammation, injure liver cells, and lay down scar tissue.

That scarring, called fibrosis, is what determines long-term risk.

Here's the part that reframes the whole conversation: fatty liver rarely travels alone. It runs with insulin resistance, high triglycerides, abnormal cholesterol, high blood pressure, and visceral fat.

It's less a standalone liver disease and more the visible tip of a metabolic iceberg.

Why the Heart Is the Real Story

This surprises people. If you have MASLD, the most likely thing to harm you isn't liver failure. It's cardiovascular disease.

Across large studies, cardiovascular disease is the leading cause of death in people with MASLD, and having the condition is associated with roughly 1.3 to 1.5 times the risk of heart attack, stroke, and other cardiac events. In people with advanced scarring, that risk climbs higher.

The same processes that damage the liver, like insulin resistance, chronic inflammation, and abnormal lipids, also damage blood vessels. So a fatty liver is a signal that your whole cardiometabolic system is under strain, and a reason to take heart health seriously.

Why "Normal" Labs Can Mislead You

Most people assume that if their liver enzymes, ALT and AST, come back normal, their liver is fine.

That assumption doesn't hold here.

Liver enzymes can sit inside the normal range even when significant scarring is present. In one study, nearly a quarter of patients with normal ALT already had advanced fibrosis. The standard "normal" cutoffs many labs use are also more lenient than what specialists consider ideal, so a result labeled fine may not be.

This is exactly why fatty liver stays hidden for so long. People are told their bloodwork looks good, and the conversation ends there.

A better approach for anyone with metabolic risk factors is a simple, well-validated screening score called FIB-4. It combines age, two standard liver enzymes, and platelet count, all from routine bloodwork, to estimate the likelihood of significant scarring.

A low score is genuinely reassuring. A higher one flags the need for a closer look, often a quick, noninvasive liver stiffness scan, before anything reaches a serious stage.

Who Should Actually Look Into This

Population-wide screening isn't recommended, and most people don't need to worry.

But guidelines do point to specific groups worth evaluating:

• Anyone with type 2 diabetes or prediabetes.

• People with central or visceral obesity plus at least one other metabolic risk factor, such as high blood pressure, high triglycerides, or low HDL.

• Anyone with liver enzymes that stay elevated over time.

Importantly, you don't have to be visibly overweight. There's a well-documented "lean" version of this condition in people with normal body weight but underlying metabolic dysfunction, which makes waist circumference and metabolic markers more telling than the number on the scale.

The Genuinely Good News

Here's what makes this worth paying attention to rather than worrying about: fatty liver is one of the most reversible conditions in metabolic health.

The liver responds. And it often responds before the scale moves much, because liver fat is quick to shift when the inputs change.

The evidence points to a few high-yield levers:

• Weight, if you're carrying excess. Losing around 7 to 10% of body weight is strongly associated with improvement, and studies show 10% or more leads to high rates of resolving inflammation and even reversing some scarring.

• A Mediterranean-style diet. Rich in vegetables, legumes, whole grains, olive oil, and fish, it has been shown to reduce liver fat and improve insulin sensitivity even without major weight loss.

• Cutting sugar-sweetened beverages. Regular soda, energy drinks, and sweetened juices are tied to roughly 40% higher odds of fatty liver, in a dose-dependent way. Fructose from drinks hits the liver hard. Whole fruit does not carry the same risk.

• Regular exercise. About 150 minutes a week of moderate activity like brisk walking meaningfully reduces liver fat, largely independent of weight change.

• Rethinking alcohol. Recent evidence suggests that in the context of metabolic dysfunction, even moderate drinking measurably raises the risk of scarring. There's no clearly "safe" amount once a fatty liver is in the picture.

None of this requires a dramatic overhaul. Sustained, modest changes over a few months can shrink liver fat, improve your metabolic markers, and lower your cardiovascular risk at the same time.

At Kora MD, this is exactly the kind of quiet, upstream problem we're built to catch. Not by waiting for a "normal" lab to reassure you, but by looking at the full metabolic picture and acting while the condition is still easy to reverse.

Your liver has been doing quiet work on your behalf for years. It's worth knowing how it's actually doing.

Reply and tell me: what should I break down next?

To your health,

Austin L. Wright

Join my inner circle - Follow me on X for daily business breakdowns, lifestyle hacks, and a behind-the-scenes look at what my team and I are building.

Follow me on IG to see how I’m living the blueprint. I practice what I preach.

P.S.

• We’re always looking to improve and create better newsletters for you in the future. If you have any feedback or suggestions for future editions, I’d love to hear from you! Just reply directly to this email and give me some ideas for how you think we could make it better!
  

• If you’re reading this online, make sure you subscribe using the button below:

_{Disclaimer: The ideas shared in this newsletter are those of the author, and this is in no way intended to be medical, legal, or financial advice. Always do your own research and consult with licensed professionals.}